Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis

Glycosylation is a ubiquitous cellular or microenvironment-specific post-translational modification that occurs on the surface of normal cells and tumor cells. Tumor cell-associated glycosylation is involved in hematogenous metastasis. A wide variety of tumors undergo aberrant glycosylation to inter...

Full description

Bibliographic Details
Main Authors: Longqiang Shu, Shanyi Lin, Shumin Zhou, Ting Yuan
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Platelets
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/09537104.2024.2315037
_version_ 1826930387461341184
author Longqiang Shu
Shanyi Lin
Shumin Zhou
Ting Yuan
author_facet Longqiang Shu
Shanyi Lin
Shumin Zhou
Ting Yuan
author_sort Longqiang Shu
collection DOAJ
description Glycosylation is a ubiquitous cellular or microenvironment-specific post-translational modification that occurs on the surface of normal cells and tumor cells. Tumor cell-associated glycosylation is involved in hematogenous metastasis. A wide variety of tumors undergo aberrant glycosylation to interact with platelets. As platelets have many opportunities to engage circulating tumor cells, they represent an important avenue into understanding the role glycosylation plays in tumor metastasis. Platelet involvement in tumor metastasis is evidenced by observations that platelets protect tumor cells from damaging shear forces and immune system attack, aid metastasis through the endothelium at specific sites, and facilitate tumor survival and colonization. During platelet-tumor-cell interactions, many opportunities for glycan-ligand binding emerge. This review integrates the latest information about glycans, their ligands, and how they mediate platelet-tumor interactions. We also discuss adaptive changes that tumors undergo upon glycan-lectin binding and the impact glycans have on targeted therapeutic strategies for treating tumors in clinical settings.
first_indexed 2024-03-07T23:44:56Z
format Article
id doaj.art-333f592f2f27485ea5acd73f4f5b397f
institution Directory Open Access Journal
issn 0953-7104
1369-1635
language English
last_indexed 2025-02-17T16:26:50Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Platelets
spelling doaj.art-333f592f2f27485ea5acd73f4f5b397f2024-12-17T06:39:35ZengTaylor & Francis GroupPlatelets0953-71041369-16352024-12-0135110.1080/09537104.2024.2315037Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasisLongqiang Shu0Shanyi Lin1Shumin Zhou2Ting Yuan3Department of Orthopedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Orthopedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaInstitute of Microsurgery on Extremities, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Orthopedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaGlycosylation is a ubiquitous cellular or microenvironment-specific post-translational modification that occurs on the surface of normal cells and tumor cells. Tumor cell-associated glycosylation is involved in hematogenous metastasis. A wide variety of tumors undergo aberrant glycosylation to interact with platelets. As platelets have many opportunities to engage circulating tumor cells, they represent an important avenue into understanding the role glycosylation plays in tumor metastasis. Platelet involvement in tumor metastasis is evidenced by observations that platelets protect tumor cells from damaging shear forces and immune system attack, aid metastasis through the endothelium at specific sites, and facilitate tumor survival and colonization. During platelet-tumor-cell interactions, many opportunities for glycan-ligand binding emerge. This review integrates the latest information about glycans, their ligands, and how they mediate platelet-tumor interactions. We also discuss adaptive changes that tumors undergo upon glycan-lectin binding and the impact glycans have on targeted therapeutic strategies for treating tumors in clinical settings.https://www.tandfonline.com/doi/10.1080/09537104.2024.2315037Cancer metastasisglycoconjugationsglycosylationlectinplatelets
spellingShingle Longqiang Shu
Shanyi Lin
Shumin Zhou
Ting Yuan
Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis
Platelets
Cancer metastasis
glycoconjugations
glycosylation
lectin
platelets
title Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis
title_full Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis
title_fullStr Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis
title_full_unstemmed Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis
title_short Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis
title_sort glycan lectin interactions between platelets and tumor cells drive hematogenous metastasis
topic Cancer metastasis
glycoconjugations
glycosylation
lectin
platelets
url https://www.tandfonline.com/doi/10.1080/09537104.2024.2315037
work_keys_str_mv AT longqiangshu glycanlectininteractionsbetweenplateletsandtumorcellsdrivehematogenousmetastasis
AT shanyilin glycanlectininteractionsbetweenplateletsandtumorcellsdrivehematogenousmetastasis
AT shuminzhou glycanlectininteractionsbetweenplateletsandtumorcellsdrivehematogenousmetastasis
AT tingyuan glycanlectininteractionsbetweenplateletsandtumorcellsdrivehematogenousmetastasis